Dr. Craig Adam Wengler, MD

Dr. Wengler practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Dr. Wengler's NPI, 1366609117, was assigned on May 20, 2008. Dr. Wengler graduated from USF Health Morsani College of Medicine in 2008. Dr. Wengler holds Florida license ME121516.

Dr. Wengler's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Dr. Wengler's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. Dr. Wengler is also affiliated with Cleveland Clinic Indian River Hospital. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Wengler to 1 more group practice or clinic, named with a free account. Dr. Wengler's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wengler practices, 3 sites in all. Vendor and product names are available with a free account.

Surgical oncology is Dr. Wengler's primary specialty in the NPI Registry, under taxonomy code 2086X0206X. Dr. Wengler is board certified in surgery by the American Board of Surgery. Dmand AI has Dr. Wengler's licenses on file in 3 states: Florida, Georgia and Ohio.

Dmand AI lists mastectomy among the conditions Dr. Wengler treats.

CMS data shows 1,404 Medicare services from Dr. Wengler across 16 procedure codes in 2024, for 428 Medicare patients. Medicare paid $162,626 for them.

CMS counts 428 Medicare patients who saw Dr. Wengler in 2024. The largest group is 65 to 74, with 199 patients. 75% of them have cancer, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Wengler's median patient age at 66, with 99% women.

In 2024, Dr. Wengler wrote 155 Medicare Part D claims for 110 patients. 100% of them were for generic drugs. CMS names the drug for 138 of them, across 4 drugs with 11 or more claims each, at $432 in total drug cost. In 2023, CMS named 129 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Wengler for performance year 2024, reported through an alternative payment model (APM). Dr. Wengler accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wengler as offering telehealth. CMS counts 73 procedures of mastectomy by Dr. Wengler, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Wengler, published from 2016 to 2017. 2017 was the busiest year, with 2. The most frequent topics are Chemotherapy, Adjuvant, Mammaplasty and Neoadjuvant Therapy. Dr. Wengler's most frequent co-authors are Rahul Dilip Tendulkar, MD, Stephanie Ann Sieg Valente, DO and Risal S. Djohan, MD.

Dmand AI links Dr. Wengler to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Carcinoma, Intraductal, Noninfiltrating, Glioblastoma and Astrocytoma. Xoft, Inc. sponsors the most, 2. Open Payments lists research payments to Dr. Wengler that name 1 trial.

CMS Open Payments shows 13 general payments to Dr. Wengler from 6 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 42% of the total. iCAD, Inc paid the most, $1,226. It also lists 7 research payments totaling $18,705 from 2021 to 2023, naming 1 clinical trial.

Dmand AI lists 15 awards for Dr. Wengler, most recently General Surgery Chief Resident in 2014.

Dr. Wengler graduated from USF Health Morsani College of Medicine in 2008. Dr. Wengler is a member of ACS, ASBS, SAGES and SSO.

Dr. Wengler is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.